 |
|
Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure
Alan S. Go, MD;
Wendy Y. Lee;
Jingrong Yang, MA;
Joan C. Lo, MD;
Jerry H. Gurwitz, MD
JAMA. 2006;296:2105-2111.
Context Whether statin therapy has beneficial effects on clinical outcomes in patients with heart failure is unclear.
Objective To evaluate the association between initiation of statin therapy and risks for death and hospitalization among adults with chronic heart failure.
Design, Setting, and Patients Propensity-adjusted cohort study of adults diagnosed with heart failure who were eligible for lipid-lowering therapy but had no previous known statin use, within an integrated health care delivery system in northern California between January 1, 1996, and December 31, 2004. Statin use was estimated from filled outpatient prescriptions in pharmacy databases.
Main Outcome Measures All-cause death and hospitalization for heart failure during a median of 2.4 years of follow-up. We examined the independent relationships between statin therapy and risks for adverse events overall and stratified by the presence or absence of coronary heart disease after multivariable adjustment for potential confounders.
Results Among 24 598 adults diagnosed with heart failure who had no prior statin use, those initiating statin therapy (n = 12 648; 51.4%) were more likely to be younger, male, and have known cardiovascular disease, diabetes, and hypertension. There were 8235 patients who died. Using an intent-to-treat approach, incident statin use was associated with lower risks of death (age- and sex-adjusted rate of 14.5 per 100 person-years with statin therapy vs 25.3 per 100 person-years without statin therapy; adjusted hazard ratio, 0.76 [95% confidence interval, 0.72-0.80]) and hospitalization for heart failure (age- and sex-adjusted rate of 21.9 per 100 person-years with statin therapy vs 31.1 per 100 person-years without statin therapy; adjusted hazard ratio, 0.79 [95% confidence interval, 0.74-0.85]) even after adjustment for the propensity to take statins, cholesterol level, use of other cardiovascular medications, and other potential confounders. Incident statin use was associated with lower adjusted risks of adverse outcomes in patients with or without known coronary heart disease.
Conclusion Among adults diagnosed with heart failure who had no prior statin use, incident statin use was independently associated with lower risks of death and hospitalization among patients with or without coronary heart disease.
Author Affiliations: Division of Research, Kaiser Permanente of Northern California, Oakland (Drs Go and Lo and Ms Yang); Departments of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco (Dr Go); Department of Medicine, Tufts School of Medicine, Boston, Mass (Ms Lee); Division of Endocrinology, Department of Medicine, San Francisco General Hospital, University of California, San Francisco (Dr Lo); and Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, Worcester (Dr Gurwitz).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
Samy Suissa
JAMA. 2007;297(10):1057.
EXTRACT
| FULL TEXT
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
Wayne Gerard and Julia Gerard
JAMA. 2007;297(10):1057-1058.
EXTRACT
| FULL TEXT
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure—Reply
Alan S. Go, Jingrong Yang, and Jerry H. Gurwitz
JAMA. 2007;297(10):1058.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Coenzyme Q10: An Independent Predictor of Mortality in Chronic Heart Failure
Molyneux et al.
J Am Coll Cardiol 2008;52:1435-1441.
ABSTRACT
| FULL TEXT
Statins and Heart Failure
Filippatos and Mikhailidis
ANGIOLOGY 2008;59:58S-61S.
ABSTRACT
Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy
Bhavnani et al.
Europace 2008;10:854-859.
ABSTRACT
| FULL TEXT
CORONA, Statins, and Heart Failure: Who Lost the Crown?
Athyros et al.
ANGIOLOGY 2008;59:5-8.
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy.
Ramasubbu et al.
J Am Coll Cardiol 2008;51:415-426.
ABSTRACT
| FULL TEXT
Rosuvastatin in Older Patients with Systolic Heart Failure
Kjekshus et al.
NEJM 2007;357:2248-2261.
ABSTRACT
| FULL TEXT
Statins May Offer Unexpected Benefits in Heart Failure
Law
DOC News 2007;4:1-8.
FULL TEXT
Reply
Goldberger and Kadish
J Am Coll Cardiol 2007;49:1372-1372.
FULL TEXT
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
Suissa
JAMA 2007;297:1057-1057.
FULL TEXT
Statin Use and Risks for Death and Hospitalization in Chronic Heart Failure
Gerard and Gerard
JAMA 2007;297:1057-1058.
FULL TEXT
JournalScan
Lindsay
Heart 2007;93:409-410.
FULL TEXT
Endocrinology & Metabolism News, December 2006
J. Clin. Endocrinol. Metab. 2006;91:17a-17a.
FULL TEXT
Statins are associated with a lower risk of death in people with heart failure
BMJ 2006;333:1014-1014.
FULL TEXT
Should Heart Failure Patients Start Taking Statins?
Journal Watch Cardiology 2006;2006:1-1.
FULL TEXT
|
